Verifying complaints of difficulties in night vision using electroretinography and dark adaptation tests.


Journal

Documenta ophthalmologica. Advances in ophthalmology
ISSN: 1573-2622
Titre abrégé: Doc Ophthalmol
Pays: Netherlands
ID NLM: 0370667

Informations de publication

Date de publication:
04 2020
Historique:
received: 21 04 2019
accepted: 04 10 2019
pubmed: 18 10 2019
medline: 11 4 2020
entrez: 18 10 2019
Statut: ppublish

Résumé

To determine the electroretinographical and psychophysical parameters that can help to verify patients' complaints of reduced night vision. We tested 275 consecutive patients with normal appearing fundi, complaining of visual difficulties at night, using flash electroretinography (ERG) and dark adaptation (DA) test. Two ERG parameters were used to assess a scotopic retinal function: the amplitude of the response to dim blue flash (the rod response) and the b-wave ratio (measured/expected). Dark adaptation was measured with green- and red-light stimuli after exposure to a bright, bleaching light. The psychophysical parameter of night vision was defined as the threshold for detection of the blue-green stimulus that was measured after 40-45 min in complete darkness. Fifty-five patients were excluded from the analysis because of a discrepancy between the two ERG parameters in assessment of scotopic retinal function. The remaining 220 patients were divided into 4 groups: (1) normal ERG and normal DA, (2) subnormal ERG and subnormal DA, (3) normal ERG and subnormal DA and (4) subnormal ERG and normal DA. The ERG and DA tests supported the complaint of visual difficulties at night in 67 patients (group 2), while 34 patients were characterized as having normal scotopic visual function (group 1). The other 119 patients (groups 3 and 4) presented a diagnostic dilemma because one test (ERG or dark adaptation) showed normal scotopic function, while the other indicated subnormal scotopic function. Our findings indicate that ERG is an essential, but not sufficient test for verifying patient's complaint on visual difficulties in the dark. We suggest using both electroretinography and psychophysical dark adaptation to test patients complaining of reduced night vision.

Identifiants

pubmed: 31621038
doi: 10.1007/s10633-019-09729-z
pii: 10.1007/s10633-019-09729-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-180

Références

Br J Ophthalmol. 1983 Jan;67(1):37-42
pubmed: 6600210
Prog Retin Eye Res. 2015 Mar;45:58-110
pubmed: 25307992
Br J Ophthalmol. 1983 Jul;67(7):443-8
pubmed: 6602626
J Gen Physiol. 1989 Jan;93(1):101-22
pubmed: 2915211
Can J Ophthalmol. 1994 Dec;29(6):280-3
pubmed: 7834567
Acta Ophthalmol. 2012 May;90(3):e192-7
pubmed: 22008250
J Neurophysiol. 2005 Jan;93(1):481-92
pubmed: 15331616
Invest Ophthalmol. 1969 Jun;8(3):332-45
pubmed: 4306337
J Med Genet. 1995 May;32(5):348-51
pubmed: 7616540
Am J Ophthalmol. 2001 Apr;131(4):495-502
pubmed: 11292414
Arch Ophthalmol. 1986 Jul;104(7):1013-20
pubmed: 3488053
Am J Ophthalmol. 2000 Nov;130(5):547-63
pubmed: 11078833
Mil Med. 2007 Apr;172(4):402-4
pubmed: 17484312
Science. 1981 Jan 9;211(4478):182-5
pubmed: 6255566
J Gen Physiol. 1937 Jul 20;20(6):831-50
pubmed: 19873031
J Physiol. 1975 Jun;248(2):413-31
pubmed: 1151791
J Clin Invest. 1994 Jun;93(6):2425-30
pubmed: 8200977
Invest Ophthalmol Vis Sci. 2000 Jan;41(1):262-6
pubmed: 10634629
Am J Ophthalmol. 1988 Sep 15;106(3):307-11
pubmed: 2971322
Am J Ophthalmol. 1954 Jul;38(1:2):70-8
pubmed: 13180620
Vis Neurosci. 1994 May-Jun;11(3):519-32
pubmed: 8038126
Doc Ophthalmol. 1992;79(2):125-39
pubmed: 1591967
Surv Ophthalmol. 2008 Jan-Feb;53(1):16-40
pubmed: 18191655

Auteurs

Gilad Allon (G)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel.

Yolanda Friedrich (Y)

Leumit Health Care, Haifa, Israel.

Eedy Mezer (E)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel.

Aviran Itzhaki (A)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Rina Leibu (R)

Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel.

Ido Perlman (I)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. iperlman@technion.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH